Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Method of treatment of cancers characterized by ligand-dependent activating mutations in FGFR2 with FGFR1 ECD proteins

Method of treatment of cancers characterized by ligand-dependent activating mutations in FGFR2 with FGFR1 ECD proteins

US Patent 9169313 · Granted Oct 27, 2015

Estimated economic value: $19,253,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Method of making afucosylated anti-FGFR2IIIB antibodies2025
Afucosylated anti-FGFR2IIIB antibodies2022
Methods of treating lung cancer2020
Method of treatment of malignant solid tumors with afucosylated anti-FGFR2IIIb a2019
Process for laying fibrous webs from a centrifugal spinning process2018
Process for laying fibrous webs from a centrifugal spinning process2017
Method of treating coronary artery disease by administering FGF-92015
Hair growth methods using FGFR3 extracellular domains2014
Method of treating coronary artery disease by administering FGF-52013
Use of FGFR1 extra cellular domain proteins to treat cancers characterized by li2013
Use of FGFR1 extra cellular domain proteins to treat cancers characterized by li2013
Method of promoting hair growth using FGFR4 extracellular domains2013